Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewPrecision Medicine Platform Zephyr AI Raises $111 Million in Series A FundingOn March 12, precision medicine platform Zephyr AI secured $111 million in Series A funding, led by Revolution Growth, Eli Lilly & Company, Jeff Skol, and EPIQ Capital Group. The new capital will further enhance the speed of the company’s platform analytics and strengthen its extensive training and validation datasets. Additionally, the funds will support the expansion of the company’s scientific and commercial teams.AI Medical Coding Platform CodaMetrix Raises $40 Million in Series B FundingOn March 12, AI medical coding platform CodaMetrix secured a $40 million Series B financing round led by Transformation Capital. The new funding will be used to further advance CodaMetrix's artificial intelligence solutions to improve the quality of medical coding, generate comprehensive clinical datasets, reduce overall care costs, and alleviate the administrative burden on providers.Regenerative Medicine Technology Developer X-Therma Secures $22.4 Million in Series B FundingOn March 13, regenerative medicine technology developer X-Therma secured $22.4 million in Series B funding, led by Starling Locke Capital. This investment enables X-Therma to expand its global commercial operations and advance into the clinical stage, achieving Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The goal is to significantly increase the availability of transplantable organs by overcoming time-sensitive limitations.Web3 Health Management Platform Live4Well Raises $20 Million in FinancingOn March 11, Web3 health management platform Live4Well secured $20 million in financing, invested by a multi-billion-dollar family office led by Miranda Wong. This investment marks a significant milestone in connecting the traditional health sector with the vast possibilities of the digital realm, particularly within the Web3 space.Minimally Invasive Robot Company Biobot Surgical Secures $18 Million in Series B FundingOn March 7, Biobot Surgical, a subsidiary of MicroPort Robotics, completed its $18 million Series B financing. The Series B funding will also enable BIOBOT to expand its global presence and further develop its digital surgery infrastructure. Mona Lisa is the first and only commercially available robotic-assisted transperineal needle positioning device.AI Protein Synthesis Platform Tierra Biosciences Secures $11.4 Million in Series A FundingOn March 12, AI protein synthesis platform Tierra Biosciences secured $11.4 million in Series A funding, led by Material Impact. This funding will also play a crucial role in advancing Tierra's predictive AI, leveraging its large and growing closed-loop synthesis parameter data pool generated from the centralized production of thousands of proteins.Consumer Microbiome Testing Company Tiny Health Raises $8.5 Million in Series A FundingOn March 5, consumer-grade microbiome testing company Tiny Health secured $8.5 million in Series A funding, led by Spero Ventures. Tiny Health's gut health test is the first product to use shotgun metagenomics sequencing, focusing on providing consumers with at-home gut microbiome testing services. The funding will accelerate Tiny Health's development plans, including expanding its enterprise customer base and enhancing product development.Health Benefits Management Platform Fijoya Raises $8.3 Million in Seed FundingOn March 7, health benefits management platform Fijoya secured $8.3 million in seed funding, led by Team8. The company’s AI-driven recommendation engine enhances the discovery and selection of personalized health benefits by matching employees with the precise health services they need from thousands of options available on the platform. The platform enables seamless payment through an embedded, on-demand, employer-funded digital card, eliminating the need for receipts or reimbursements.Wearable Device Developer PreemptiveAI Secures $6.4 Million in New Round of FinancingOn March 6, wearable device developer PreemptiveAI secured $6.4 million in a new round of financing. The company is committed to building the most predictive large-scale healthcare models, leveraging biomedical signals from smartphones and wearable devices to develop AI software for predicting health outcomes. The new round of funding highlights the enormous potential of artificial intelligence in the healthcare sector, paving the way for more advanced solutions in future health prediction and monitoring.Digital Healthcare Platform Foundation Health Secures $6 Million in Seed FundingOn March 11, healthcare digitalization platform Foundation Health secured $6 million in seed funding. Investors in this round included Garry Tan (CEO of Y Combinator), Transpose Platform, Tuesday VC, and others. The funds will be used to accelerate product development, expand the customer base, and ensure that Foundation Health accurately meets market demands.Healthcare Cost Management Platform Milu Health Secures $4.8 Million in Seed FundingOn March 11, Milu Health, a medical cost management platform, secured $4.8 million in seed funding led by Andreessen Horowitz (a16z) Bio + Health, with participation from investors including BoxGroup, PagsGroup, and 81 Collection. Milu will use the funds to further develop its technology platform and expand its operations.Nest Health, a home care service provider, raises $4 million in seed fundingOn March 12, Nest Health, a home care service provider, raised $4 million in seed funding led by SpringTide. Nest Health is the first value-based healthcare practice designed for the home. Nest Health provides convenient and compassionate primary care to parents and children through in-home visits, virtual care, and 24/7 medical, behavioral, and social support.DocNow, a Nursing Electronic Health Record System, Completes Seed Round FinancingOn March 7, DocNow, an electronic health record system for nursing, completed its seed funding round led by Waterline Ventures. The amount of financing was not disclosed. The company plans to use the funds to accelerate the development of innovative features, expand in the post-acute care sector, and continue its customer-centric approach.02 Digital Health Industry Dynamics
Gilead Sciences and Merus Reach Research Collaboration and Licensing AgreementOn March 7, Gilead Sciences and Merus announced a research collaboration and licensing agreement to jointly develop trispecific antibodies targeting novel tumor-associated antigens (TAA). Under the terms of the agreement, Merus will receive a $56 million upfront payment and a $25 million investment from Gilead. Across all potential programs, Merus is also eligible to receive up to $1.5 billion in payments, including potential development and commercialization milestone payments.C4 Therapeutics Collaborates with Merck KGaA to Develop Cancer Protein Degradation TherapiesOn March 5, C4 Therapeutics (C4T) announced that it had entered into a licensing and collaboration agreement with Merck KGaA of Germany to co-develop targeted protein degraders aimed at two key oncogenic protein targets advanced in C4T’s internal discovery pipeline. Under the terms of the agreement, C4T will receive an upfront payment of $16 million. C4T is eligible to receive up to approximately $740 million in discovery, regulatory, and commercial milestone payments throughout the collaboration.BridgeBio Pharma and Bayer Establish PartnershipOn March 5, BridgeBio Pharma and Bayer announced a partnership, with BridgeBio granting Bayer the exclusive license to commercialize acoramidis, an investigational therapy for treating transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), in Europe. BridgeBio will receive up to $310 million in upfront payments and near-term milestones.03 Global Digital Health M&A OverviewJohnson & Johnson has successfully completed the acquisition of Ambrx Biopharma.On March 7, Johnson & Johnson announced the successful completion of its acquisition of Ambrx Biopharma, Inc. Ambrx Biopharma is a clinical-stage biopharmaceutical company with a proprietary synthetic biology platform used to design and develop next-generation ADCs. The acquisition was completed in an all-cash merger transaction with a total equity value of approximately $2 billion (approximately RMB 14.3 billion at the time), and a net amount of $1.9 billion after deducting the estimated acquired cash.Bruker to Acquire ELITech Group for $942 MillionOn February 28, Bruker signed an acquisition agreement to acquire ELITechGroup, a provider of in vitro diagnostic systems, for $942 million (approximately RMB 6.77 billion). Reportedly, the transaction does not include ELITech's clinical chemistry business and is expected to close in the second quarter of 2024. After the completion of the transaction, ELITech is expected to become an independent business unit under Bruker’s microbiology and infectious disease diagnostics division, forming part of the CALID Group where Bruker's life sciences and mass spectrometry businesses are located.ArteryNet/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/FierceHealth, etc.
Compiled by: Zhang Qiankun
